CLARITY MEDICAL (01406)
| Auditor | From | To | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|
| Crowe | 29-Mar-26 | |||
| Ernst & Young | 26-Oct-22 | 31-Mar-26 | Could not reach a consensus on the timetable and costs to complete the 2025 Audit, and any further delay would adversely affect the overall progress of the resumption in trading of the Company’s shares. EY said it is unable to assess the scope of additional audit procedures that will be required in order for it to complete the 2025 Audit without the satisfactory completion of the Independent Investigations into the two sets of allegations. | |
| Crowe Horwath (Hk) | 29-Mar-26 | Replaced by new auditor | ||
| Pwc | 26-Oct-22 | As good corporate governance measure, the Company should consider a rotation of its independent auditors after an appropriate period of time. |